Riskpilot← Back to searchSign inGet full accessCARDIAC CONSULT ApS
APSIn liquidationCVR 31370213Amagertorv 11Other education n.e.c. · NACE 8559Est. 20081 employees
Revenue 2025
DKK -68K
-65% vs 2024
EBITDA margin
136.7%
+79% vs 2024
Equity ratio
72.5%
Financial strength
Net profit 2025
DKK -322K
+62% vs 2024
| Revenue | DKK -68K | -65% |
| EBITDA | DKK -93K | +79% |
| Net profit | DKK -322K | +62% |
| Total assets | DKK 10,4M | -4% |
| Equity | DKK 7,5M | -4% |
| Employees | 1 | — |
Legal name
CARDIAC CONSULT ApS
CVR number
31370213
Legal form
Anpartsselskab
NACE code
8559 · Other education n.e.c.
Founded
9. april 2008
Share capital
DKK 128.000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Company purpose
Selskabets formål er at drive rådgivningsvirksomhed samt udføre undervisning og supervision af patientbehandling samt hermed beslægtet virksomhed.
Address
Amagertorv 11
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2.397 | 3.886 | 3.071 | -197 | -68 |
| Staff expenses | -422 | -444 | -420 | -255 | -25 |
| EBITDA | 1.975 | 3.441 | 2.651 | -452 | -93 |
| Depreciation & amort. | -221 | -400 | -399 | -380 | -174 |
| EBIT | 1.754 | 3.042 | 2.253 | -832 | -267 |
| Net financials | 4.257 | 735 | -50 | -54 | -52 |
| Profit before tax | 6.011 | 3.777 | 2.203 | -886 | -318 |
| Tax | 1.022 | 922 | 588 | -48 | 3 |
| Net profit | 4.989 | 2.855 | 1.615 | -838 | -322 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 12.469 | 11.861 | 12.731 | 10.826 | 10.404 |
| Equity | 7.978 | 7.333 | 8.948 | 7.860 | 7.538 |
| Long-term debt | 2.949 | 2.849 | 2.746 | 2.642 | 2.538 |
| Short-term debt | 1.542 | 1.679 | 1.038 | 324 | 328 |
| Total debt | 4.491 | 4.528 | 3.783 | 2.966 | 2.866 |
EBITDA margin
-9308500.0%
This company
15.8%
Market median
-58914657% vs market
20212025
Equity ratio
72.5%
This company
38.2%
Market median
+90% vs market
20212025
Return on equity
-4.3%
This company
18.4%
Market median
-123% vs market
20212025
Net profit margin
-32173900.0%
This company
8.1%
Market median
-397208742% vs market
20212025
Asset turnover
-0.01×
This company
1.12×
Market median
-101% vs market
20212025
Debt / equity
0.38×
This company
0.62×
Market median
+39% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HH Unofficial title | Unofficial title | 2026 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 90–99.99% | 100% | 2010 | |
| Individual | 0% | 0% | 2010 | |
| Individual | 0% | 0% | 2010 | |
| Individual | 0% | 0% | 2010 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CARDIAC CONSULT ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hans Henrik Skjødt | Unofficial title | 0 companies |